Profit Or Loss [Abstract]

BerGenBio - Filing #2542730

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
354,000 NOK
389,000 NOK
Profit (loss) from operating activities
191,819,000 NOK
305,635,000 NOK
Finance income
13,409,000 NOK
15,027,000 NOK
Finance costs
11,991,000 NOK
11,514,000 NOK
Profit (loss) before tax
190,401,000 NOK
302,122,000 NOK
Tax expense (income)
0 NOK
0 NOK
Profit (loss)
0 NOK
0 NOK
190,401,000 NOK
190,401,000 NOK
0 NOK
0 NOK
302,122,000 NOK
302,122,000 NOK
0 NOK
0 NOK
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.13
3.41
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
0.13
3.41

Talk to a Data Expert

Have a question? We'll get back to you promptly.